Hyloris Pharmaceuticals SA
XBRU:HYL

Watchlist Manager
Hyloris Pharmaceuticals SA Logo
Hyloris Pharmaceuticals SA
XBRU:HYL
Watchlist
Price: 4.29 EUR -6.94% Market Closed
Market Cap: 120.1m EUR
Have any thoughts about
Hyloris Pharmaceuticals SA?
Write Note

Hyloris Pharmaceuticals SA
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hyloris Pharmaceuticals SA
EPS (Diluted) Peer Comparison

Comparables:
UCB
TUB

Competitive EPS (Diluted) Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Hyloris Pharmaceuticals SA
XBRU:HYL
EPS (Diluted)
€0
CAGR 3-Years
-19%
CAGR 5-Years
21%
CAGR 10-Years
N/A
Ucb SA
XBRU:UCB
EPS (Diluted)
€1
CAGR 3-Years
-23%
CAGR 5-Years
-16%
CAGR 10-Years
N/A
Financiere de Tubize SA
XBRU:TUB
EPS (Diluted)
€4
CAGR 3-Years
-18%
CAGR 5-Years
-5%
CAGR 10-Years
10%

See Also

What is Hyloris Pharmaceuticals SA's EPS (Diluted)?
EPS (Diluted)
-0.6 EUR

Based on the financial report for Dec 31, 2023, Hyloris Pharmaceuticals SA's EPS (Diluted) amounts to -0.6 EUR.

What is Hyloris Pharmaceuticals SA's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 5Y
21%

Over the last year, the EPS (Diluted) growth was -25%. The average annual EPS (Diluted) growth rates for Hyloris Pharmaceuticals SA have been -19% over the past three years , 21% over the past five years .

Back to Top